Misguided Pricing Tactics Delay Access To Medicines Warns NHS England

Misguided Pricing Tactics Delay Access To Medicines, Warns NHS England

06:38 EDT 15 May 2019 | Elsevier Business Intelligence

Pharmaceutical companies must not delay patient access to medicine through “salami slicing” pricing strategies, says Blak...

Original Article: Misguided Pricing Tactics Delay Access To Medicines, Warns NHS England

More From BioPortfolio on "Misguided Pricing Tactics Delay Access To Medicines, Warns NHS England"